However, IL-33 neutralisation in vivo led to a more quiescent tumour characterised by the infiltration of CD4+ T cells producing interferon gamma (IFNγ) (Th1-like) and decreased Th2-like cells (CD8+ and CD4+ T cells expressing IL-4) in the tumour microenvironment. The gene discussed is IL33; the disease is neoplasm.